https://ajmcrr.com/index.php/pub/issue/feed American Journal of Medical and Clinical Research & Reviews 2026-03-10T04:15:56+03:00 Editor ajmcrr@gmail.com Open Journal Systems <p><strong>Impact Factor 1.167</strong></p> <p><strong>American Journal of Medical and Clinical Research &amp; Reviews (ISSN 2835-6276) </strong>is an internationally reputed open access journal that aims to publish a Low, Education and Biological diversity Multisisciplinary Sciences journal wide range of topics within the field of general medicine, advanced medicine, and its related clinical practices.The journal seeks original research in all the major clinical and medical sciences in the form of research articles, review articles, case studies, commentaries, short communication, and the letters to the editor This peer reviewed journal publishes evidence based empirical research on a wide range of topics within the fields of general medicine that includes Cardiology, Nephrology, Gynecology, Dermatology, Dentistry, Ophthalmology, Orthopedices, Neurology and Immunology for publication. The journal lays equal emphasis on the advanced scientific research on pediatrics, Critical care medicine, Family Medicine, Epidemiology, and Geriatrics. Specialized fields within the Translational Medicine, Nursing, Epidemiology, and Healthcare are encouraged for publication.</p> <p>Research on the major clinical practices involved in the general and advanced medical practices including but not limited to oncology, HIV/Aids, Infectious diseases, Surgery, Internal medicine, Orthopedics, and Neurology finds a place in this scientific journal.</p> https://ajmcrr.com/index.php/pub/article/view/396 A Comment of Osteoarthritis of Knee 2026-03-01T18:58:16+03:00 Saccomanni Bernardino bernasacco@yahoo.it <p>-</p> 2026-03-01T00:00:00+03:00 Copyright (c) 2026 American Journal of Medical and Clinical Research & Reviews https://ajmcrr.com/index.php/pub/article/view/392 Diagnosis, Pathophysiology and Management of Stercoral Colitis 2026-03-10T04:15:56+03:00 Perry Hookman g278298@gmail.com <p><em>Stercolitis,[1] also known as stercoral colitis, is a serious inflammatory condition of the colon caused by pressure necrosis from impacted fecal matter. The term derives from the Latin "stercus" (feces) and "-itis" (inflammation). This condition occurs when hardened stool masses (fecoliths) remain lodged in the colon for extended periods, leading to ischemia, ulceration, and potentially life-threatening perforation of the bowel wall. Prognosis correlates directly with the timing of diagnosis and intervention.</em></p> <p><em>Early recognition and treatment significantly improve outcomes, while delayed diagnosis with perforation carries substantial mortality risk.</em></p> 2026-03-05T00:00:00+03:00 Copyright (c) 2026 American Journal of Medical and Clinical Research & Reviews https://ajmcrr.com/index.php/pub/article/view/387 Shabbat “Beyond Time” and the Physics of Time: A Mystical Deep Dive with a Careful Bridge to Modern Physics 2026-03-10T03:58:32+03:00 Julian Ungar-Sargon jyungar@icloud.com <p><em>This article examines the concept of Shabbat as “beyond time” (le-ma’alah min ha-zeman) through a sustained engagement with Zoharic Kabbalah and Hasidic thought, followed by a carefully delimited bridge to Richard Feynman’s physics of time. Beginning with the Zohar’s architecture of “two Shabbatot” and its association of the upper Shabbat with the sefirah of Binah, the analysis traces how Hasidic masters—including the Maggid of Mezritch, R. Menahem Nahum of Chernobyl (Meor Einayim), R. Shneur Zalman of Liadi, R. Levi Yitzchak of Berditchev, the Sefat Emet, and the Mei HaShiloach—transformed Zoharic metaphysics into a lived phenomenology of temporal transcendence. Drawing on the scholarship of Arthur Green, Elliot Wolfson, Michael Fishbane, Eitan Fishbane, Moshe Idel, and Rivka Schatz-Uffenheimer, the article reconstructs a coherent Hasidic theology of Shabbat-time. It then offers Feynman’s treatment of relativity and the path-integral formulation as analogical—not identical—resources for understanding why “one linear story” is not the deepest description of reality, either in physics or in the mystical apprehension of sacred time.</em></p> 2026-03-05T00:00:00+03:00 Copyright (c) 2026 American Journal of Medical and Clinical Research & Reviews https://ajmcrr.com/index.php/pub/article/view/395 Treatment of hair loss with an LED device: the importance of the wave length 2026-02-26T15:27:25+03:00 Hausdorfer S susanne.hausdorfer@gmail.com <p><em>Hair loss is of a big concern in our society, concerning about 50% of the population at one time of their life. It impacts social integration and the feeling of well-being.</em></p> <p><em>We will distinguish hair loss with and without inflammatory causes, both having to be treated differently. Number of sessions, wave lengths, and energy levels will be discussed. Red light (630 nm) alone will be used in hair loss without inflammation, such is seen in crash dieting, postpartum, or after chemotherapy. The combination of IR-red light is necessary to have conclusive results in the other case, such as alopecia areata. The presence of hair bulbs is necessary to achieve regrowth. Instead of biopsies in already scarce hair, I performed clinical photographs, always in the same position; one before treatment, one after 5 sessions, and one after ten sessions. If necessary, treatment could be continued once a month.</em></p> <p><em>This is a retrospective review of more than 600 cases, successfully treated in my praxis. The effects are durable, in time except in pathologies with an inflammatory component where a couple of new treatment sessions are necessary.</em></p> <p><em>Using this method in every day practice is very easy as treatment sessions take about 15 minutes and the method is very successful when applied correctly. The treatment is very safe with virtually no side effects and permits to reduce other medication used for this purpose.</em></p> 2026-03-01T00:00:00+03:00 Copyright (c) 2026 American Journal of Medical and Clinical Research & Reviews https://ajmcrr.com/index.php/pub/article/view/388 Vaccination Strategies in Adult Dialysis Patients: A Global, Temperate‑Tropical Epidemiological Feature 2026-01-23T13:34:10+03:00 Anita L R Saldanha taniabelluci@uol.com.br Ana Paula Pantoja Margeotto taniabelluci@uol.com.br André Luis Valera Gasparoto taniabelluci@uol.com.br Tania Leme da Rocha Martinez taniabelluci@uol.com.br <p><strong><em>Background: </em></strong><em>Patients receiving maintenance dialysis have elevated risks of vaccine‑preventable infections and reduced vaccine immunogenicity due to uremia‑associated immune dysfunction and repeated healthcare exposure. Geographic variation in infectious burden influences vaccination strategy implementation. </em></p> <p><strong><em>Objective: </em></strong><em>To comprehensively review immunization procedures in adult dialysis patients, integrating immunologic mechanisms, clinical effectiveness, global epidemiologic variation (temperate vs tropical differences), and implementation practices. </em></p> <p><strong><em>Methods: </em></strong><em>Narrative synthesis of systematic reviews, clinical studies, and expert recommendations pertaining to vaccine immunogenicity and clinical outcomes in chronic kidney disease and dialysis populations. </em></p> <p><strong><em>Results: </em></strong><em>Enhanced hepatitis B vaccine regimens improve seroprotection and survival. Combined influenza and pneumococcal vaccination are associated with reduced all‑cause mortality in dialysis patients. COVID‑19 vaccination elicits robust humoral responses with acceptable safety profiles, though effectiveness is lower than in healthy controls. Tropical regions face higher endemic burdens of hepatitis B and year‑round influenza, requiring context‑adapted protocols. Implementation science suggests dialysis‑unit–based vaccination programs improve uptake and outcomes. </em></p> <p><strong><em>Conclusion: </em></strong><em>Immunization in dialysis patients requires higher‑dose regimens, booster strategies, and context‑specific adaptation to regional epidemiologic patterns. Dialysis facilities should adopt structured vaccination frameworks to reduce infection‑related morbidity and mortality globally.</em></p> 2026-03-01T00:00:00+03:00 Copyright (c) 2026 American Journal of Medical and Clinical Research & Reviews